“…(20,21) Primary antibodies against CD24a (Biolegend, San Diego, CA), CD81, CD44, CD45 (Pharmingen, Franklin Lakes, NJ), TrkB (R&D, Minneapolis, MN), CD200 (Serotec, Dü sseldorf, Germany), Igf2r, Fgfr3 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), or Pthr1 (Abcam, Cambridge, UK) were incubated on sections and detected by secondary antibodies conjugated with Alexa or Cy-dyes (Molecular Probes, Jackson, West Grove, PA, USA). Incubations of sections with secondary antibodies only were used as negative controls.…”